SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-085545
Filing Date
2024-04-03
Accepted
2024-04-03 09:27:05
Documents
15
Period of Report
2024-04-03
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d793644d8k.htm   iXBRL 8-K 41220
2 EX-2.2 d793644dex22.htm EX-2.2 138196
  Complete submission text file 0001193125-24-085545.txt   385717

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA xoma-20240403.xsd EX-101.SCH 3867
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE xoma-20240403_def.xml EX-101.DEF 14108
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE xoma-20240403_lab.xml EX-101.LAB 23492
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xoma-20240403_pre.xml EX-101.PRE 15141
19 EXTRACTED XBRL INSTANCE DOCUMENT d793644d8k_htm.xml XML 7044
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 24817087
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)